MARCH BIOSCIENCES INC
HOUSTON, TX · Founded 2021 · CIK 0001965802 · Biotech · Private
CAR-T cell therapies for hematological cancers
march.bio →- Grants
- $3.1M
- 3 awards
- Sector median: 1
- Raised
- $22M
- 2 Form D · Oct 2024
- 23 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $8,870 | |
| Federal grant | Department of Health and Human Services · Phase II · Dual-targeting allogeneic CAR T-cells for universal therapy of T-cell malignancies | $1,013,623 | |
| Private capital raised | Form D · SEC | $22,140,942 | |
| Federal grant | Department of Health and Human Services · Phase II · A Phase 2 multi-center trial of CD5 CAR T-cell therapy in patients with T-cell lymphoma | $1,124,607 | |
| Federal grant | Department of Health and Human Services · Phase II · Dual-targeting allogeneic CAR T-cells for universal therapy of T-cell malignancies | $986,080 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2361 | Allinaire Therapeutics, LLC | — | $950K |
| 2362 | ECM Therapeutics, Inc. | — | $919K |
| 2363 | ACRIGEN BIOSCIENCES, INC. | — | $775K |
| 2364 | MARCH BIOSCIENCES INC | — | $22M |
| 2365 | Biodesy LLC | — | $350K |
| 2366 | Montara Therapeutics | — | $28M |
| 2367 | VST BIO Corp | — | $29M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Sarah HeinDirector · Executive Officer
- Thomas LubyDirector
- Maksim MamonkinDirector · Executive Officer
- Peter OlagunjuDirector
- Joseph PetrosinoDirector
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.